Contemporary Pediatrics, Digital Edition, February 2012

Food Insecurity and the Dangers of Infant Formula Dilution

The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency.

January 30th 2023

Screen use and ways to protect pediatric eyesight

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN

Demystifying Infant Formula

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the latest issue of Contemporary Pediatrics.

October 11th 2022

FDA approves remestemcel-L-rknd to treat steroid-refractory acute graft-versus-host disease

$FDA approves remestemcel-L-rknd to treat steroid-refractory acute graft-versus-host disease | Image Credit: © Calin - © Calin - stock.adobe.com.$

Joshua Fitch, Senior Editor

December 18th 2024

2-week-old girl with lesions on her lips, cheeks, and nasolabial folds

With the federal agency's decision, remestemcel-L-rknd has become the first FDA-approved mesenchymal stromal cell therapy.

Fordyce spots in neonates are benign, requiring no intervention | Image credit: Author provided

Apurva Dev;Bernard A Cohen, MD

December 18th 2024

FDA expands setmelanotide indication to patients as young as 2 years

Can you diagnose this healthy, 8.2-lb girl with lesions primarily on her lower lip but also her upper lip, cheeks, and nasolabial folds?

Related Content

Joshua Fitch, Senior Editor

Food Insecurity and the Dangers of Infant Formula Dilution

The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency.

January 30th 2023

Screen use and ways to protect pediatric eyesight

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN

Demystifying Infant Formula

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the latest issue of Contemporary Pediatrics.

October 11th 2022